Some people sail through childhood with barely a sniffle, only to develop worsening seasonal allergies, eczema flare-ups, or new food sensitivities well into adulthood. Allergic disease tends to build cumulatively, shaped by repeated exposures, changing hormones, and shifts in the immune system over time, and genetics plays a real role in setting the stage for that trajectory. One foundational gene is FLG, which builds filaggrin, a protein essential to a properly sealed skin barrier. Loss-of-function mutations in this gene are considered the strongest and best-characterized genetic risk factor for atopic dermatitis identified to date (Kiyohara et al., 2015). Genetics is one piece of a larger, cumulative picture, not a fixed sentence.
Contents
FLG and the Skin Barrier’s Role in the “Allergic March”
Filaggrin helps bind and compact skin cells into a tight, protective outer layer. When this protein is deficient, the skin barrier becomes leakier, allowing allergens to penetrate more easily and setting off immune sensitization that can extend well beyond the skin itself.
Why Skin Problems Can Predict Later Allergies
Roughly 10% of the general population carries at least one FLG loss-of-function mutation, and children with these mutations tend to develop earlier-onset, more severe, and more chronic atopic dermatitis (Thyssen et al., 2012). This pattern fits with what allergists call the “atopic march”: skin barrier problems in early life are thought to promote allergen sensitization through the skin, which can later show up as food allergy, allergic rhinitis, or asthma, conditions that often accumulate rather than resolve as a person ages.
A Genuinely Population-Specific Story
It’s worth being honest that FLG’s effect isn’t uniform everywhere. While the mutations are well-documented and common in European and Japanese populations, a study in Turkish children found these same mutations were rare and showed no significant association with food allergy or atopic dermatitis in that population (Cetinkaya et al., 2021), and a separate study in South African patients found decreased filaggrin breakdown products without any of the known loss-of-function mutations at all. Different populations appear to carry different, population-specific FLG variants, which is a useful reminder against assuming one well-studied mutation applies everywhere.
IL33 and IL1RL1: An Alarm System That Can Stay Switched On
IL-33 functions as an “alarmin,” a signal released when tissue is damaged that alerts the immune system to potential threats. It binds to a receptor built from the IL1RL1 gene, and together this pathway is one of the most consistently replicated genetic findings in asthma and allergic disease research (Christenson et al., 2016).
Variants in this pathway have been specifically linked to intermediate- and late-onset wheezing patterns that are closely tied to allergic sensitization occurring in early childhood, suggesting this pathway helps set a trajectory that can play out over years (Savenije et al., 2014). Interestingly, researchers have also identified a rare loss-of-function IL33 mutation that does the opposite: it lowers eosinophil counts, the immune cells central to allergic inflammation, and is associated with meaningfully reduced asthma risk (Smith et al., 2017). This pathway has become significant enough that IL-33-blocking drugs are now in clinical use for certain allergic conditions, underscoring how central this alarm system appears to be.
ORMDL3: A Strong Signal With an Unclear Mechanism
A region on chromosome 17q21 containing the ORMDL3 gene produced one of the most replicated findings in the history of asthma genetics, first identified in a landmark 2007 study and since confirmed across German, British, Mexican, and Chinese populations (Ferreira & Zhao, 2019).
What makes this one worth including here is its honest complexity: the association was originally and most strongly tied to childhood-onset asthma, and one review specifically noted the 17q21 locus is linked to childhood nonallergic asthma, distinguishing it from classic allergen-driven disease. Even so, a study in a Chinese Han population found the same locus significantly associated with adult-onset asthma as well, suggesting its relevance may extend across the lifespan (Li et al., 2011). Despite over 15 years of research confirming the statistical association, the precise biological mechanism connecting ORMDL3 to airway disease is still being worked out, involving sphingolipid metabolism and cellular stress responses that researchers are still mapping in detail.
What Else Shapes Allergies Over a Lifetime
Cumulative allergen exposure, changes in gut and skin microbiome composition, hormonal shifts, air pollution, respiratory infections, and even where you live all interact with genetic tendencies to shape how allergies evolve over decades. New adult-onset allergies or a worsening of childhood allergies are common enough that they’re worth discussing with an allergist, since specific testing can identify concrete triggers regardless of the underlying genetic contribution.
Where Genetic Testing Fits In
If your allergies have shifted or intensified over the years, an allergies genetic report can walk through markers like these in personalized detail. It’s meant to build understanding of your biology, not to replace allergy testing or a consultation with an allergist.
Frequently Asked Questions
Can you develop new allergies as an adult even without a childhood history?
Yes. Adult-onset allergies are common and can develop even in people with no prior allergic history, influenced by a combination of genetic tendencies and cumulative environmental exposures over time.
Does having eczema as a baby mean I’ll definitely develop other allergies?
Not definitely, but research on the “atopic march” shows a statistical tendency for early skin barrier problems to precede other allergic conditions later in childhood and beyond. It’s a risk pattern, not a guarantee.
Is there a genetic test that predicts which specific allergens I’ll react to?
Not currently in a clinically reliable way. Genetic markers can indicate a general tendency toward allergic disease, but identifying specific trigger allergens still requires standard allergy testing like skin prick or blood IgE tests.
